A Double-Blind, Double-Dummy, Parallel Group, Randomised Study to Compare the Efficacy and Tolerability of Oxycodone/Naloxone Prolonged Release (OXN PR) and Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis.

Trial Profile

A Double-Blind, Double-Dummy, Parallel Group, Randomised Study to Compare the Efficacy and Tolerability of Oxycodone/Naloxone Prolonged Release (OXN PR) and Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2014

At a glance

  • Drugs Oxycodone/naloxone (Primary) ; Paracetamol/codeine
  • Indications Back pain; Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms EASE
  • Sponsors Napp Pharmaceutical Group
  • Most Recent Events

    • 01 Nov 2011 Actual end date Jun 2011 added as reported by ClinicalTrials.gov.
    • 01 Nov 2011 Actual initiation date changed from Jan 2009 to Feb 2009 as reported by ClinicalTrials.gov.
    • 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top